News

More than 1 million people undergo total joint replacements each year, and nearly 10,000 will develop infections. To reduce this infection risk, an orthopedic surgeon has created small antibiotic beads that are implanted with the new joint to slowly release medicine for several weeks.

Researchers have developed a new line of attack against cancer: an organic-osmium compound, which is triggered using a non-toxic dose of sodium formate, a natural product found in many organisms, including nettles and ants.

A team of researchers has pioneered a new water-based air-conditioning system that cools air to as low as 18 degrees Celsius without the use of energy-intensive compressors and environmentally harmful chemical refrigerants. This game-changing technology could potentially replace the century-old air-cooling principle that is still being used in our modern-day air-conditioners.

A biochemical study has produced reliable figures estimating protein number in simple cells for the first time.

Scientists now report results showing that, by cloaking anti-cancer drugs in a specially designed particle, they could target and destroy tumor cells deep inside a malignant mass in vitro.

The first study of a nationally-representative group of U.S. infants reports that more than half of babies are currently introduced to complementary foods, that is, foods or drinks other than breast milk or formula, sooner than they should be.

Watered-down or fake liquors can reap financial rewards for nefarious individuals, but the adulteration of liquor cheats consumers and can even lead to health hazards from added contaminants. Scientists now report a portable device with an advanced sensor array that can identify liquors and determine if they'd been altered, offering a strategy for liquor quality assurance.

People with focal epilepsy are significantly more likely to suffer from mood disorders such as depression, a new study suggests.

Scientists have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus. The research builds on previous studies showing that an antibody called MR191 can neutralize Marburg—though no one knew exactly how it targeted the virus.

The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.